Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

NCT06575686 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

33

Enrollment

OTHER

Sponsor class

Stopped Pending Interim Analysis

Conditions

Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3a Follicular Lymphoma
Refractory Grade 1 Follicular Lymphoma
Refractory Grade 2 Follicular Lymphoma
Refractory Grade 3a Follicular Lymphoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Epcoritamab
PROCEDURE: Positron Emission Tomography
DRUG: Tazemetostat

Sponsor

City of Hope Medical Center

Collaborators

[object Object]